BANK OF AMERICA CORP /DE/
BankPosition in LGND — Ligand Pharmaceuticals Inc
CIK 70858
CHARLOTTE, NC
Position in LGND
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$31,517,745
+$8,797,395 QoQ
Shares Held
157,865
+31.4% QoQ
Ownership
0.788%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 30.22582586387103.ToString("F0")%
Shared 0.ToString("F0")%
None 69.77417413612898.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. LGND ranks #61 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in LGND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,517,745 | 157,865 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $22,720,350 | 120,169 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $21,683,526 | 122,409 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $13,165,050 | 115,808 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,565,201 | 100,487 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,512,086 | 107,439 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,500,039 | 104,906 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,632,434 | 102,450 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,945,846 | 149,738 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,049,031 | 112,700 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,421,085 | 107,161 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,405,938 | 88,848 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,041,259 | 82,127 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,961,034 | 74,267 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,256,734 | 97,858 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,195,113 | 75,373 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,713,308 | 124,166 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,214,029 | 85,246 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $6,759,664 | 77,776 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,709,755 | 81,986 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $7,310,841 | 76,873 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $13,841,471 | 223,106 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $13,165,336 | 221,402 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $11,232,859 | 160,986 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $5,786,199 | 127,548 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||